Across TCGA pan-cancer cohorts, PPIAP4 RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated PPIAP4 data layer.
The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher PPIAP4 RNA is associated with better overall survival. In most high-consensus cancer types, elevated PPIAP4 expression acts as an unfavorable survival marker, although some lineages such as BLCA and KIRP show a favorable association.
BLCA, KIRP, and ACC are the cancer types where PPIAP4 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.